Patents by Inventor James Jacob Mond

James Jacob Mond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
    Patent number: 7777017
    Abstract: The present invention encompasses monoclonal antibodies that bind to lipoteichoic acid (LTA) of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro. The invention also provides antibodies having human sequences (chimeric, humanized and human antibodies). The invention also sets forth the variable regions of three antibodies within the invention and presents the striking homology between them.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: August 17, 2010
    Assignee: Biosynexus Incorporated
    Inventors: Jeffrey R. Stinson, Richard F. Schuman, James Jacob Mond, Andrew Lees, Gerald Walter Fischer
  • Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
    Publication number: 20030211995
    Abstract: This invention provides lysostaphin intranasal compositions that can be administered to the anterior nares of those at risk for staphylococcal nasal colonization and subsequent infection and methods for their use.
    Type: Application
    Filed: December 20, 2002
    Publication date: November 13, 2003
    Inventors: John Fitzgerald Kokai-Kun, Scott Michael Walsh, James Jacob Mond, Tatyana Ivanovna Chanturiya